Date on which the terms and conditions of the subsequent offering/repair offering were announced: 11 March 2025; Date of approval: Expected to be on or about 11 April 2025 by resolution of an ...

The board of directors of the Company has resolved not to proceed with the Subsequent Offering. The background for the cancellation is that the Company's shares have traded at or below the ...

Permitting issuers to submit draft registration statements regardless of how much time has passed since they become subject to Exchange Act reporting requirements Expanding the availability of the ...

The Subsequent Offering will be carried out as set out in an offering prospectus (which must be approved by the Norwegian Financial Supervisory Authority) to be published prior to commencement of ...

The board of directors of the Company has resolved not to proceed with the Subsequent Offering. The background for the cancellation is that the Company's shares have traded at or below the ...

Date on which the terms and conditions of the subsequent offering/repair offering were announced: 11 March 2025; Date of approval: Expected to be on or about 11 April 2025 by resolution of an ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION ...

Reference is made to the stock exchange notice from IDEX Biometrics ASA ("IDEX" or the "Company") on 11 March 2025 regarding irrevocable undertakings from certain existing shareholders for a total ...